35 results on '"Neǵrier, C"'
Search Results
2. Investigation of Underlying Reasons of Factor VIII Deficiency in Hemophilia A Patients with Undetectable Mutations in the F8 Gene
3. Current Clinical Investigations Involving FEIBA
4. Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels
5. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
6. Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency
7. Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study
8. Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate
9. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study
10. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography
11. Conception et suivi de l’implantation nationale de la formation HEMOPHAR, destinée aux pharmaciens d’officine prenant en charge des patients traités par emicizumab
12. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey
13. Two novel mutations in EGF‐like domains of human factor IX dramatically impair intracellular processing and secretion
14. Monitoring the bioavailability of FEIBA with a thrombin generation assay
15. The P-selectin cytoplasmic domain directs the cellular storage of a recombinant chimeric factor IX
16. Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability
17. PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA
18. Gene therapy for hemophilia? Yes
19. PSY223 - QUALITATIVE RESEARCH IN HAEMOPHILIA A: EMICIZUMAB TRANSFORMS LIFESTYLE OF PATIENTS WITH INHIBITOR
20. Accessibility measure for haemophilia patients: Study of anti-haemophilic factors availability in the Rhône-Alpes County, France
21. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
22. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH
23. Reversal of the inhibitory effect of Fondaparinux on Thrombin generation by rFVIIa, aCCP and PCC
24. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
25. Centre de référence des pathologies plaquettaires
26. Adaptability of protein A-immunoadsorption allows temporary reduction of anti-VIII antibodies and realisation of high-risk haemorrhagic surgery
27. Thromboélastométrie rotative : réhabilitation de l'ancienne thromboélastographie
28. Intérêt de l'analyse de la mesure optique du TCA sur l'automate MDA II (bioMérieux) dans la prise en charge des patients avec syndrome de réponse inflammatoire systémique
29. OC-13 Enhanced expression of Mda-9/syntenin induced through the tissue-factor pathway in melanoma promotes tumor cell migration and invasion
30. P3 A score based prevention strategy of venous thromboembolism in pregnant women
31. La protection des données nominatives informatiques en matière de recherche médicale
32. Les bases thérapeutiques actuelles de l’hémophilie
33. Increased Thrombin Generation in α Child With α Combined Factor IX and Protein C Deficiency
34. Treatment of interleukin-2-induced thrombocytopenia by intravenous immunoglobulin
35. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.